Last edition
News about Global Pharma
ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to Alzheimer's disease (AD) pathology.
Global Pharma | 22/04/2025 | By Manvi | 485
Sanoculis Receives CE Mark Approval for MINT Glaucoma Surgery Device in EU
Sanoculis Ltd. announced that it has received CE Mark approval under the Medical Device Regulation (MDR) in the European Union (EU) for its MINT® (Minimally Invasive Nasal Trabeculostomy) product—an innovative, stent-free technology platform for the treatment of adult patients undergoing glaucoma angle surgery.
Global Pharma | 21/04/2025 | By Manvi | 305
FDA Classifies Q'Apel Medical's Recall of 072 Aspiration System as Class I
US Food and Drug Administration, classified Q'Apel Medical, Inc.'s voluntary recall of 1,617 units of its 072 Aspiration System (also known under the product name 'Hippo', which includes 'Cheetah'; collectively, the 'product') as Class I.
Global Pharma | 21/04/2025 | By Manvi | 267
Zydus MedTech Partners with Braile Biomedica to Commercialise TAVI Technology
Zydus MedTech has partnered with Brazil-based Braile Biomedica to exclusively commercialise its advanced Transcatheter Aortic Valve Implantation (TAVI) technology across Europe, India, and select global markets, marking its strategic entry into the interventional cardiology space.
Global Pharma | 21/04/2025 | By Manvi | 519
Alembic Pharmaceuticals Secures USFDA Final Approval for Carbamazepine Tablets
Alembic Pharmaceuticals has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Carbamazepine Tablets USP, 200 mg, a generic version of Tegretol used as an anticonvulsant and for treating trigeminal neuralgia.
Global Pharma | 21/04/2025 | By Manvi | 269
Lupin Secures EIR from US FDA for its Injectable Facility in Nagpur
Lupin has received the Establishment Inspection Report (EIR) from the US FDA for drug-device combination products at its injectable manufacturing facility in Nagpur, India.
Global Pharma | 21/04/2025 | By Manvi | 1184
RND Automation Acquires QuickPouch's Intellectual Property and Asset
With this acquisition, RND plans to improve the QuickPouch product line and integrate it into their renowned packaging solutions, including the MiniPack, MicroPack, and Kanga Poucher.
Global Pharma | 19/04/2025 | By Manvi | 350
FDA Approves Medtronic's Simplera Sync Sensor for Use with MiniMed 780G System
With this approval, the MiniMed™ 780G system now offers more flexibility for users of the company's most advanced insulin delivery system featuring Meal Detection™ technology with both the Guardian™ 4 sensor and Simplera Sync™ sensor.
Global Pharma | 19/04/2025 | By Manvi | 699
EBR Systems Secures FDA Approval for WiSE System to Treat Advanced Heart Failure
Unlike conventional CRT, the WiSE System is the first and only to deliver leadless left ventricular endocardial pacing (LVEP), that closely aligns with the heart's natural conduction pathway.
Global Pharma | 19/04/2025 | By Abha | 629
WuXi Biologics Completes First Commercial PPQ Campaign at MFG20 Hangzhou Facility
WuXi Biologics completes the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000L single-use bioreactors (SUBs).
Global Pharma | 19/04/2025 | By Abha | 323
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy